Silvia Damaso

2 ta ish

GlaxoSmithKline (United Kingdom)

1. Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

   Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez +33

   MaqolaOAOchiq kirish20062 iqtibos

   ABIABI:AkademIndex/2026.other.205053

2. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

   Timo Vesikari, Aino Karvonen, Roman Prymula +7

   Maqola20072 iqtibos

   ABIABI:AkademIndex/2026.other.359383